ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo

matching placebo to RO4995819 oral once daily for 6 weeks

DRUG

RO4995819

5 mg oral once daily for 6 weeks

DRUG

RO4995819

15 mg oral once daily for 6 weeks

DRUG

RO4995819

30 mg oral once daily for 6 weeks

Trial Locations (92)

1090

Vienna

Wien, Vienna

6020

Innsbruck

7130

Cape Town, Western Cape

7530

Bellville, Cape Town

7925

Cape Town, Western CAPE

10021

New York

10029

New York

10032

New York

14618

Rochester

16515

Oranienburg

19046

Jenkintown

19053

Schwerin, Mecklenburg-Vorpommern

19063

Media

21005

Vinnytsia

21208

Baltimore

23298

Richmond

24014

Roanoke

27710

Durham

29201

Columbia

30076

Roswell

30080

Smyrna

30308

Atlanta

32216

Jacksonville

32607

Gainsville

33067

Coral Springs

33161

North Miami

33319

Lauderhill

34471

Ocala

39232

Flowood

44122

Beachwood

44718

Canton

45215

Cincinnati

45227

Cincinnati

49005

Dnipropetrovsk

61068

Kharkiv

63368

O'Fallon

65006

Odesa

66206

Prairie Village

67214

Wichita

68159

Mannheim

73479

Ellwangen

73488

Kherson,Vil. Stepanivka

73760

Ostfildern

76012

Arlington

77030

Houston

80239

Denver

83008

Donetsk

84106

Salt Lake City

85381

Phoenix

87131

Albuquerque

90402

Nuremberg

90502

Torrance

92103

San Diego

92295

Victorville

92374

Redlands

94305

Stanford

94607

Oakland

95006

Simferopol, Crimea

117105

Moscow

117995

Moscow

150003

Yaroslavl

163530

Talagi

190121

Saint Petersburg

191119

Saint Petersburg

192019

Saint Petersburg

199004

Saint Petersburg

214019

Smolensk

399083

Lipetsk

443016

Samara

620030

Yekaterinburg

620036

Yekaterinburg

630091

Novosibirsk

634014

Tomsk

60612-3244

Chicago

02114

Boston

02472

Watertown

B4N 4K9

Kentville

K7L 4X3

Kingston

K1Z 7K4

Ottowa

J9A 1k7

Gatineau

J1H 4J6

Sherbrooke

H4H 1R3

Verdun

04275

Leipzig

811 07

Bratislava

813 69

Bratislava

851 01

Bratislava

979 01

Rimavská Sobota

911 01

Trenčín

0046

Centurion, Pretoria

0181

Nieu Muckleneuk, Pretoria

02660

Kiev

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01457677 - ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment | Biotech Hunter | Biotech Hunter